HFG Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
HFG Advisors's ELV Position: Q1 2026 in Review
HFG Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 605 shares — an estimated $212K sold.
HFG Advisors first reported a position in ELV in Q4 2021 and held it in 17 quarters. The position peaked at $635K in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- HFG Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- HFG Advisors sold 605 Elevance Health shares in Q1 2026, an estimated $212K.
- HFG Advisors first reported a position in Elevance Health in Q4 2021 and held it in 17 quarters.
- HFG Advisors's Elevance Health position peaked at $635K in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on HFG Advisors's 13F filing for Q1 2026, filed 8 May 2026.